Copyright Reports & Markets. All rights reserved.

Global Bladder Cancer Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Bladder Cancer Market Overview

      • 1.1 Product Overview and Scope of Bladder Cancer
      • 1.2 Bladder Cancer Segment by Type
        • 1.2.1 Global Bladder Cancer Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Intravesical therapy
        • 1.2.3 Chemotherapy
        • 1.2.4 Preservation therapy
      • 1.3 Bladder Cancer Segment by Application
        • 1.3.1 Bladder Cancer Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.4 Global Bladder Cancer Market by Region
        • 1.4.1 Global Bladder Cancer Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Bladder Cancer Market Size
        • 1.5.1 Global Bladder Cancer Revenue (2014-2025)
        • 1.5.2 Global Bladder Cancer Production (2014-2025)

      2 Global Bladder Cancer Market Competition by Manufacturers

      • 2.1 Global Bladder Cancer Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Bladder Cancer Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Bladder Cancer Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Bladder Cancer Production Sites, Area Served, Product Types
      • 2.5 Bladder Cancer Market Competitive Situation and Trends
        • 2.5.1 Bladder Cancer Market Concentration Rate
        • 2.5.2 Bladder Cancer Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Bladder Cancer Production Market Share by Regions

      • 3.1 Global Bladder Cancer Production Market Share by Regions
      • 3.2 Global Bladder Cancer Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Bladder Cancer Production
        • 3.4.1 North America Bladder Cancer Production Growth Rate (2014-2019)
        • 3.4.2 North America Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Bladder Cancer Production
        • 3.5.1 Europe Bladder Cancer Production Growth Rate (2014-2019)
        • 3.5.2 Europe Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Bladder Cancer Production (2014-2019)
        • 3.6.1 China Bladder Cancer Production Growth Rate (2014-2019)
        • 3.6.2 China Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Bladder Cancer Production (2014-2019)
        • 3.7.1 Japan Bladder Cancer Production Growth Rate (2014-2019)
        • 3.7.2 Japan Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Bladder Cancer Consumption by Regions

      • 4.1 Global Bladder Cancer Consumption by Regions
      • 4.2 North America Bladder Cancer Consumption (2014-2019)
      • 4.3 Europe Bladder Cancer Consumption (2014-2019)
      • 4.4 China Bladder Cancer Consumption (2014-2019)
      • 4.5 Japan Bladder Cancer Consumption (2014-2019)

      5 Global Bladder Cancer Production, Revenue, Price Trend by Type

      • 5.1 Global Bladder Cancer Production Market Share by Type (2014-2019)
      • 5.2 Global Bladder Cancer Revenue Market Share by Type (2014-2019)
      • 5.3 Global Bladder Cancer Price by Type (2014-2019)
      • 5.4 Global Bladder Cancer Production Growth by Type (2014-2019)

      6 Global Bladder Cancer Market Analysis by Applications

      • 6.1 Global Bladder Cancer Consumption Market Share by Application (2014-2019)
      • 6.2 Global Bladder Cancer Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Bladder Cancer Business

      • 7.1 Bristol-Myers Squibb
        • 7.1.1 Bristol-Myers Squibb Bladder Cancer Production Sites and Area Served
        • 7.1.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.1.3 Bristol-Myers Squibb Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eli Lilly
        • 7.2.1 Eli Lilly Bladder Cancer Production Sites and Area Served
        • 7.2.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.2.3 Eli Lilly Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 F. Hoffman-La Roche
        • 7.3.1 F. Hoffman-La Roche Bladder Cancer Production Sites and Area Served
        • 7.3.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.3.3 F. Hoffman-La Roche Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Pfizer
        • 7.4.1 Pfizer Bladder Cancer Production Sites and Area Served
        • 7.4.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.4.3 Pfizer Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Accord Healthcare
        • 7.5.1 Accord Healthcare Bladder Cancer Production Sites and Area Served
        • 7.5.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.5.3 Accord Healthcare Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 AstraZeneca
        • 7.6.1 AstraZeneca Bladder Cancer Production Sites and Area Served
        • 7.6.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.6.3 AstraZeneca Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Bedford Lab
        • 7.7.1 Bedford Lab Bladder Cancer Production Sites and Area Served
        • 7.7.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.7.3 Bedford Lab Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Merck
        • 7.8.1 Merck Bladder Cancer Production Sites and Area Served
        • 7.8.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.8.3 Merck Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Sanofi
        • 7.9.1 Sanofi Bladder Cancer Production Sites and Area Served
        • 7.9.2 Bladder Cancer Product Introduction, Application and Specification
        • 7.9.3 Sanofi Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Bladder Cancer Manufacturing Cost Analysis

      • 8.1 Bladder Cancer Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Bladder Cancer
      • 8.4 Bladder Cancer Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Bladder Cancer Distributors List
      • 9.3 Bladder Cancer Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Bladder Cancer Market Forecast

      • 11.1 Global Bladder Cancer Production, Revenue Forecast
        • 11.1.1 Global Bladder Cancer Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Bladder Cancer Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Bladder Cancer Price and Trend Forecast (2019-2025)
      • 11.2 Global Bladder Cancer Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Bladder Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Bladder Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Bladder Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Bladder Cancer Production, Revenue Forecast (2019-2025)
      • 11.3 Global Bladder Cancer Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Bladder Cancer Consumption Forecast (2019-2025)
        • 11.3.2 Europe Bladder Cancer Consumption Forecast (2019-2025)
        • 11.3.3 China Bladder Cancer Consumption Forecast (2019-2025)
        • 11.3.4 Japan Bladder Cancer Consumption Forecast (2019-2025)
      • 11.4 Global Bladder Cancer Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Bladder Cancer Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Bladder cancer is known to be a urologic malignancy that occurs in the tissues of the urinary bladder. It is generally characterized by the uncontrolled division of cells arising from the epithelial lining and may proliferate to the muscular wall of the urinary bladder. The exact causes of bladder cancer are still unknown.

        The global Bladder Cancer market is valued at 460 million US$ in 2018 is expected to reach 1140 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025.
        This report focuses on Bladder Cancer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bladder Cancer market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Bristol-Myers Squibb
        Eli Lilly
        F. Hoffman-La Roche
        Pfizer
        Accord Healthcare
        AstraZeneca
        Bedford Lab
        Merck
        Sanofi

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Intravesical therapy
        Chemotherapy
        Preservation therapy

        Segment by Application
        Hospital
        Clinic

        Buy now